Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 15,000 shares at $19.61 ($295K) on 2017-06-20, disclosed to the SEC on 2017-06-22.
Open-market sale of $295k RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.61 | 13,100 | $257K | 87.0% |
| 2 | $20.14 | 1,900 | $38K | 13.0% |
| Total | $19.68 avg | 15,000 | $295K | 100% |
| Filing → |
| RGNX | SELL | 2018-11-07 | $2.5M | — | Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |